Orchestra BioMed Holdings (OBIO) Equity Average: 2022-2025
Historic Equity Average for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $22.0 million.
- Orchestra BioMed Holdings' Equity Average fell 51.26% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year decrease of 51.26%. This contributed to the annual value of $50.5 million for FY2024, which is 16.24% down from last year.
- Orchestra BioMed Holdings' Equity Average amounted to $22.0 million in Q3 2025, which was up 156.73% from $8.6 million recorded in Q2 2025.
- Orchestra BioMed Holdings' 5-year Equity Average high stood at $94.6 million for Q2 2023, and its period low was -$5.7 million during Q3 2022.
- Its 3-year average for Equity Average is $53.0 million, with a median of $50.7 million in 2024.
- As far as peak fluctuations go, Orchestra BioMed Holdings' Equity Average spiked by 2,063.76% in 2023, and later crashed by 83.07% in 2025.
- Over the past 4 years, Orchestra BioMed Holdings' Equity Average (Quarterly) stood at $23.2 million in 2022, then soared by 217.86% to $73.8 million in 2023, then crashed by 46.39% to $39.6 million in 2024, then crashed by 51.26% to $22.0 million in 2025.
- Its last three reported values are $22.0 million in Q3 2025, $8.6 million for Q2 2025, and $24.9 million during Q1 2025.